← Ashitaba

Tomorrow's Leaf: Longevity, Anti-Inflammatory, and Metabolic Health

How the Japanese herb Ashitaba and its unique chalcone compounds support cellular longevity, reduce inflammation, and improve blood sugar regulation.

Ashitaba — Japanese for "tomorrow's leaf" — is a tall, aromatic plant native to Japan's Izu Peninsula, eaten as a vegetable and prized in traditional medicine for centuries as a longevity tonic [1]. Its thick, yellow sap contains a family of plant compounds called prenylated chalcones that are rare in other foods, and researchers have found these chalcones can activate autophagy (your cells' own recycling and cleaning system), suppress inflammation, and improve blood sugar regulation [2][3]. The plant earned its name from its rapid regrowth: cut a leaf today, and a new one appears tomorrow — a quality the Japanese associated with vitality and renewal. For those looking to expand their phytonutrient repertoire beyond the usual greens, ashitaba offers a concentrated dose of unusual compounds in a mild-tasting, versatile food.

What Makes Ashitaba Different: The Chalcone Compounds

Most leafy greens provide quercetin, kaempferol, and other common flavonoids. Ashitaba's distinction lies in two prenylated chalcones found primarily in its root sap and young shoots: 4-hydroxyderricin (4-HD) and xanthoangelol (XA). These are not found in significant quantities in any other common food. Ashitaba also contains 4,4′-dimethoxychalcone (DMC), which has attracted particular scientific interest for its ability to activate autophagy [1][2].

Chalcones are structurally simpler flavonoids — essentially the open-chain precursors to flavones and flavanones. This structural openness may contribute to their ability to interact with a wider range of protein targets compared to the more rigid ring-closed flavonoids common in other plants.

How the Chalcones Work

Autophagy activation. In 2019, a study in Nature Communications showed that DMC — detected in ashitaba — extends the lifespan of yeast, worms, and fruit flies while decelerating senescence in human cell cultures [2]. DMC achieved this by inhibiting specific GATA transcription factors, triggering autophagy through a pathway independent of mTOR — meaning it activates cellular recycling through a different entry point than fasting or rapamycin. In mice, DMC also protected against myocardial ischemia (reduced cardiac cell death during a simulated heart attack). The study attracted significant attention because it identified a dietary compound that activates the "longevity shortcut" of autophagy across multiple organisms.

Anti-inflammatory action. 4-HD and XA inhibit key inflammatory signaling in immune cells [3]. When macrophages are stimulated with LPS (bacterial lipopolysaccharide) — a standard model of immune activation — both compounds significantly suppress nitric oxide production, TNF-α secretion, and iNOS and COX-2 enzyme expression. The underlying mechanism involves interference with NF-κB signaling, the same inflammatory master switch that NSAID drugs target — but through a distinct pathway.

Blood sugar and insulin signaling. 4-HD acts as a PPARγ agonist — binding to the same nuclear receptor that thiazolidinedione diabetes drugs target. This promotes adiponectin secretion and GLUT4-dependent glucose uptake in fat cells, improving insulin sensitivity. The chalcones also activate AMPK (the cellular fuel sensor), which increases GLUT4 translocation to cell membranes — a direct mechanism for clearing glucose from the bloodstream.

How to Use Ashitaba

As a food. In Japan, young ashitaba leaves and stems are eaten as a vegetable — blanched, stir-fried, used in tempura, or added to green drinks. The flavor is mild and slightly herbal, similar to celery leaf. The yellow sap that appears when a stem is cut is the most concentrated source of chalcones.

As a supplement. Ashitaba extract powders and capsules are available internationally, typically standardized to chalcone content. Doses used in research range from 200–500 mg of extract daily. Look for products standardized to 4-HD and/or XA content rather than generic "ashitaba powder."

Practical notes. The chalcones are heat-sensitive — prolonged high-heat cooking degrades them. Light blanching or raw use preserves more active compounds. Ashitaba has been consumed as a food vegetable in Japan for generations with no significant reported toxicity [1].

Cross-references: Autophagy | Anti-Inflammatory Foods | Insulin Resistance | Fisetin

Evidence Review

Overview of the Research Landscape

The pharmacology of ashitaba was comprehensively reviewed by Caesar and Cech in Planta Medica (PMID 27399234) [1]. The authors catalogued in vitro and in vivo evidence for cytotoxic, antidiabetic, antioxidative, anti-inflammatory, antihypertensive, and antimicrobial activities across ashitaba's major compound classes: prenylated chalcones, linear and angular coumarins, and flavanones. Their key caveat: the bulk of studies are in vitro or in rodent models, and clinical evidence in humans was limited as of 2016. That situation has partially improved with subsequent studies, including a human metabolomics trial published in 2019.

Autophagy and Cross-Species Longevity: The DMC Study

Eisenberg et al. (2019, PMID 30783116) in Nature Communications [2] screened 180 natural compounds for autophagy-inducing activity and identified 4,4′-dimethoxychalcone (DMC) as a top candidate. Key findings:

  • Yeast (S. cerevisiae): DMC extended replicative lifespan significantly (p < 0.001); the effect was abolished in autophagy-deficient mutants, confirming mechanistic dependence.
  • Worms (C. elegans): Median lifespan increased; again abolished in autophagy-deficient worms.
  • Flies (Drosophila): Mean lifespan extension observed in wild-type but not autophagy-deficient flies.
  • Human cell cultures: DMC decelerated cellular senescence markers across multiple cell lines.
  • Mice: DMC administered prior to coronary artery occlusion significantly reduced myocardial infarct size — a cardioprotective effect.

The molecular mechanism identified was inhibition of GATA transcription factors (specifically GATA2 and GATA3 in mammalian cells), which de-repressed autophagy gene transcription. This is mechanistically distinct from TORC1-dependent autophagy induced by fasting, rapamycin, or spermidine, suggesting possible additive effects. The study used purified DMC, not whole-plant material; DMC content in food-grade ashitaba products varies and has not been standardized in most commercial extracts.

Lifespan and Healthspan in Drosophila

Jafari et al. (2023, PMID 37242522) [4] used whole Angelica keiskei extract to test effects on lifespan in four Drosophila strains of both sexes. Results were notably sex-dependent:

  • In female flies: ashitaba extract extended median and maximum lifespan in multiple strains and improved reproductive output.
  • In male flies: effects were neutral or slightly negative depending on strain.

The sex-specific pattern was proposed to relate to interactions between the chalcone scaffold (which has structural similarity to phytoestrogens) and sex hormone signaling in flies. The study used 2% (w/v) extract in food, representing a moderate dietary dose relative to fly body weight. Translating these findings to human applications requires caution given the large biological differences between insect and mammalian hormonal physiology.

Anti-Inflammatory Mechanisms: Macrophage Data

Yasuda et al. (2014, PMID 24369884) [3] characterized the anti-inflammatory actions of 4-HD and XA in LPS-stimulated RAW264 mouse macrophages:

  • NO production: markedly reduced by 4-HD at 10 μM and XA at 5 μM (both p < 0.001)
  • TNF-α secretion: significantly suppressed by both chalcones at sub-cytotoxic concentrations
  • iNOS protein expression: reduced dose-dependently
  • COX-2 expression: similarly suppressed
  • NF-κB nuclear translocation: inhibited, confirming this as the upstream target

Cytotoxicity assays confirmed all inhibitory effects occurred at concentrations well below toxic thresholds. The study is in vitro, so direct extrapolation to human anti-inflammatory effects is not warranted. However, the concentrations showing activity are estimated to be achievable in intestinal tissue given the absorption and distribution data available for these chalcones in rodent studies.

Human Metabolomics: Plasma Changes After Ashitaba Intake

Oh et al. (2019, PMID 31283957) [5] performed a metabolomics and lipidomics study using plasma from 20 human subjects before and after Angelica keiskei intake. Using UPLC-Orbitrap mass spectrometry, the researchers identified 14 significantly changed plasma metabolites following consumption. The altered metabolites included:

  • Kynurenic acid (neuroprotective tryptophan-pathway metabolite)
  • Prostaglandin E1 (endogenous anti-inflammatory eicosanoid)
  • Chenodeoxycholic acid (bile acid relevant to metabolic syndrome risk)
  • Multiple lysophosphatidylcholines (membrane and inflammatory signaling lipids)

The directional changes in these metabolites were consistent with reduced risk profiles for liver disease, type 2 diabetes, anemia, obesity, atherosclerosis, and inflammation. This is an exploratory study with significant limitations: small sample (n=20), no placebo control, and no long-term follow-up. Its value is confirmatory — establishing that ashitaba compounds are absorbed and produce measurable metabolic shifts in humans — rather than demonstrating clinical efficacy.

Strength of Evidence Assessment

Strong (mechanistically and cross-species validated): The autophagy-induction story via DMC is compelling, independently replicated across yeast, worms, flies, cell culture, and mice, with clear mechanistic characterization. The anti-inflammatory chalcone data is consistent across multiple in vitro studies by independent research groups.

Moderate (suggestive, limited): The human metabolomics data is preliminary. No large-scale RCTs have been conducted using ashitaba or isolated chalcones for any clinical endpoint in humans. Most metabolic effects — blood sugar improvement, AMPK activation, adiponectin secretion — are demonstrated in cell culture or rodent models and await clinical confirmation. The sex-dependent lifespan findings in flies are intriguing but the human relevance is uncertain.

Overall, ashitaba is best understood as an emerging longevity food with a credible mechanistic basis and promising preliminary evidence, rather than a proven clinical intervention. For those interested in dietary diversity and phytonutrient breadth, it represents a reasonable addition with a favorable safety profile rooted in centuries of culinary use in Japan.

References

  1. A Review of the Medicinal Uses and Pharmacology of AshitabaCaesar LK, Cech NB. Planta Medica, 2016. PubMed 27399234 →
  2. The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across speciesEisenberg T, Abdellatif M, Schroeder S, et al.. Nature Communications, 2019. PubMed 30783116 →
  3. Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophagesYasuda M, Kawabata K, Miyashita M, Okumura M, Yamamoto N, Takahashi M, Ashida H, Ohigashi H. Journal of Agricultural and Food Chemistry, 2014. PubMed 24369884 →
  4. Angelica keiskei Impacts the Lifespan and Healthspan of Drosophila melanogaster in a Sex and Strain-Dependent MannerJafari M, Schriner SE, Kil YS, Pham ST, Seo EK. Pharmaceuticals, 2023. PubMed 37242522 →
  5. Analysis of plasma metabolic profiling and evaluation of the effect of the intake of Angelica keiskei using metabolomics and lipidomicsOh HA, Lee H, Park SY, Lim Y, Kwon O, Kim JY, Kim D, Jung BH. Journal of Ethnopharmacology, 2019. PubMed 31283957 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.